3//SEC Filing
Elutia PIPE Investment, LP 3
Accession 0001994488-23-000002
CIK 0001708527other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 10:24 AM ET
Size
6.8 KB
Accession
0001994488-23-000002
Insider Transaction Report
Form 3
ELUTIA INC.ELUT
Elutia PIPE Investment, LP
10% Owner
Holdings
- 1,436,077
Class A Common Stock
Warrants (right to buy)
Exercise: $1.43From: 2023-09-21→ Class A Common Stock (2,154,116 underlying)
Footnotes (4)
- [F1]The reported securities are included within the 1,436,077 Units purchased by the reporting person for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock and one warrant to purchase one and one-half shares of Class A Common Stock.
- [F2]Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP II, LLC, which is the general partner of HighCape Partners GP II, L.P., which is the general partner of Elutia PIPE Investment, LP.
- [F3]The securities reported herein do not include shares of Class A Common Stock included within: (i) 1,372,415 Units held by HighCape Partners QP II, L.P., and (ii) 28,636 Units held by HighCape Partners II, L.P., which securities were included on a Form 4 filed by those entities on October 5, 2023.
- [F4]The warrant expires upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope or (b) September 21, 2028.
Documents
Issuer
ELUTIA INC.
CIK 0001708527
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001994488
Filing Metadata
- Form type
- 3
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 10:24 AM ET
- Size
- 6.8 KB